Pharmacokinetic interaction between metoprolol and SP-8203 in rats: competitive inhibition for the metabolism of metoprolol by SP-8203 via hepatic CYP2D subfamily

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
Seung Yon HanYoung Hee Choi

Abstract

1. The occurrence of cerebral ischemia is prevalent in patients with hypertension and the combination drug therapy is needed. Thus, the pharmacokinetic interaction between metoprolol (anti-hypertension drug) and SP-8203 (a new drug candidate for cerebral ischemia) with respect to the metabolism via CYP isozymes was evaluated. 2. Metoprolol and SP-8203 were administered intravenously or orally to rats. Concentrations (I) of each drug in the liver and intestine in in vivo studies, the disappearance and apparent K(i) of each drug in in vitro microsomes and [I]/K(i) ratios for each drug were determined. In addition, the disappearance of each drug via CYPs in rat and human microsomes were measured. 3. The AUC and CL(NR) of intravenously administered metoprolol with SP-8203 were significantly greater and slower, respectively, than without SP-8203. However, pharmacokinetic parameters of oral metoprolol and intravenous/oral SP-8203 were not altered. 4. The hepatic metabolism of metoprolol via CYP2D was inhibited by SP-8203 in a competitive manner. However, the intestinal metabolism of metoprolol was not influenced by SP-8203. SP-8203 was not metabolized via CYP isozymes in rats and then co-administration of metoprolol did not affect th...Continue Reading

References

Oct 1, 1975·Clinical Pharmacology and Therapeutics·G R Wilkinson, D G Shand
Jan 1, 1992·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P Soucek, I Gut
Jun 1, 1989·American Journal of Hypertension·S Strandgaard, O B Paulson
Dec 1, 1983·Journal of Pharmacokinetics and Biopharmaceutics·M G Lee, W L Chiou
Jan 1, 1995·Methods in Enzymology·R G Duggleby
Jul 9, 1994·Lancet·P K Whelton
Oct 6, 1997·The Medical Clinics of North America·J He, P K Whelton
Jan 6, 1999·Archives of Pharmacal Research·E H Joo, Y B Lee
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·S EkinsS A Wrighton
Aug 10, 2002·Journal of Cellular and Molecular Medicine·R ZuberP Anzenbacher
May 12, 2005·The Annals of Pharmacotherapy·Kenneth A Bachmann, Jeffrey D Lewis
Aug 29, 2006·Journal of Pharmaceutical Sciences·Young H ChoiMyung G Lee
Dec 1, 2006·Journal of the Neurological Sciences·Tomasz DziedzicAndrzej Szczudlik
Mar 3, 2007·Biological & Pharmaceutical Bulletin·Hiroko TanabeYukiya Hashimoto
Sep 11, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Rose HayeshiAnna-Lena Ungell
Dec 22, 2010·Pharmacology, Biochemistry, and Behavior·Su-Jin NohYoo-Hun Suh

❮ Previous
Next ❯

Citations

Aug 30, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Unji LeeHee E Kang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.